Inside the body, some seemingly harmless proteins have sinister potential. In the case of Alzheimer's disease, the amyloid-beta (Aβ) protein, which is vital for brain growth, can become tainted and destroy cells, which leads ...
Jun 14, 2022
0
35
Researchers have known for many years that Alzheimer's disease involves two proteins called amyloid beta and tau, and that interaction between them drives the spread of neurodegeneration. What hasn't been clear is where and ...
Apr 27, 2022
0
6
Three experimental blood tests used to identify people in early stages of Alzheimer's disease perform differently in Black individuals compared to white individuals, according to a new study from Washington University School ...
Apr 21, 2022
0
3
In addition to memory problems and other cognitive symptoms, most people with Alzheimer's disease also suffer from mental health issues. It has long been unclear whether these occur because of tissue changes in the brain, ...
Apr 19, 2022
0
16
Medical guidelines meant to reduce risk for heart disease focus on levels of cholesterol in the blood, including low-density lipoproteins (LDL), labeled "bad cholesterol," and high-density lipoproteins (HDL), labeled as "good." ...
Apr 13, 2022
0
51
An anti-inflammatory drug candidate, known as 3,6'-dithiopomalidomide (DP) and designed by researchers at the National Institute on Aging (NIA), protected lab mice against cognitive decline by reducing brain inflammation. ...
Mar 2, 2022
0
20
Among people with no memory or thinking problems, having a poor score on a simple memory test may be linked to biomarkers in the brain associated with Alzheimer's disease as well as very early signs of memory impairment that ...
Feb 23, 2022
0
96
Researchers at the Technion—Israel institute of Technology, in collaboration with researchers from CNRS, recently published findings about the development of an artificial molecule that may inhibit the development of Alzheimer's ...
Jan 19, 2022
0
13
Patients hospitalized for COVID-19 had higher levels over the short term of blood proteins known to rise with neurological damage than non-COVID-19 patients diagnosed with Alzheimer's disease, a new study finds.
Jan 13, 2022
0
13
(HealthDay)—It's a move that could severely limit the number of people taking the controversial new Alzheimer's drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled ...
Jan 12, 2022
0
13
